Additionally, high expression of ANXA1/2/5/6 were found in BC patients with stage III/IV compared to those in BC patients with stage I/II (Figure 4B–E), whereas low expression of ANXA10 were found in stage III/IV BC patients (Figure 4F). Here, ANXA10 is linked to breast cancer.